Novo Nordisk
NVO
#21
Rank
$462.97 B
Marketcap
$101.99
Share price
-3.16%
Change (1 day)
2.81%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of September 2024 : $11.21 Billion USD

According to Novo Nordisk's latest financial reports the company has $11.21 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$4.47 B31.88%
2022-12-31$3.39 B27.53%
2021-12-31$2.66 B26.24%
2020-12-31$2.10 B-9.12%
2019-12-31$2.32 B-3.16%
2018-12-31$2.39 B-21.17%
2017-12-31$3.03 B3.7%
2016-12-31$2.93 B-2.28%
2015-12-31$2.99 B15.45%
2014-12-31$2.59 B-3.03%
2013-12-31$2.67 B-6.19%
2012-12-31$2.85 B-6.34%
2011-12-31$3.04 B6.44%
2010-12-31$2.86 B15.94%
2009-12-31$2.47 B29.19%
2008-12-31$1.91 B32.34%
2007-12-31$1.44 B59.73%
2006-12-31$0.90 B13.87%
2005-12-31$0.79 B9.4%
2004-12-31$0.72 B38.6%
2003-12-31$0.52 B109.32%
2002-12-31$0.25 B-42.9%
2001-12-31$0.43 B139.08%
2000-12-31$0.18 B0.3%
1999-12-31$0.18 B59.72%
1998-12-31$0.11 B-29.1%
1997-12-31$0.16 B22.89%
1996-12-31$0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$9.95 B-11.28%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.51 B-68.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.09 B-27.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.28 B-35.06%๐Ÿ‡ซ๐Ÿ‡ท France